Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.6/5
Darktrace (DARK LN)
Watchlist
Contact IR
28
Analysis
Information Technology
•
United Kingdom
Darktrace PLC operates as an AI company. The Company develops immune system platform which leverages unsupervised machine learning to detect cyber-threats. Darktrace serves customers worldwide.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Darktrace
•
25 Apr 2024 10:28
Quiddity Leaderboard SE600 Mar 24: 7 Changes Likely; Expected ADDs Could Outperform Expected DELs
My latest estimate for one-way flow is US$95mn. The expected ADDs have strong positive momentum while the expected DELs have strong negative momentum.
Janaghan Jeyakumar, CFA
Follow
361 Views
Share
bullish
•
Rubrik
•
06 Apr 2024 19:56
Rubrik IPO Preview and Valuation Analysis: 2024’s Hottest SaaS Investment Opportunity
In my in-depth insight, I highlight Rubrik's potential as a top investment opportunity in the software IPO market this year
Andrei Zakharov
Follow
879 Views
Share
bullish
•
NEL ASA
•
19 Oct 2023 10:03
Quiddity Leaderboard SE600 Dec 23: Novartis-Sandoz, Dechra, CHR, and Others
I currently see six regular ADDs/DELs for the SE600 index in December 2023. Apart from that the Dechra and CHR deals could trigger two more intra...
Janaghan Jeyakumar, CFA
Follow
635 Views
Share
bullish
•
Synthomer
•
26 Sep 2023 10:50
Quiddity Leaderboard SE600 Dec 23: 7 Changes Possible Including Two Intra-Review Changes
If the Dechra Pharma and Chr Hansen deals close prior to the Dec 23 review, there will be intra-review replacements. Synthomer and Adevinta are...
Janaghan Jeyakumar, CFA
Follow
589 Views
Share
bullish
•
Darktrace
•
10 Jan 2023 21:16
Darktrace: Undervalued Cyber Defense Unicorn. A Steep Discount Is Unjustified
Our analysis suggests Darktrace shares look undervalued relative to peers, and we believe a steep discount is unjustified
Andrei Zakharov
Follow
462 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.54.8
x